Prostaglandin-producing suppressor cells in Hodgkin's disease.
about
Diseases associated with immunosuppressionThe use of concanavalin A to study the immunoregulation of human T cellsCharacterization of a human blood monocyte subset with low peroxidase activity.Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.Modulation by thymus-derived (T) cells of thyroid cell-stimulated prostaglandin E release by human peripheral blood mononuclear cells.Effect of indomethacin in vivo on humoral and cellular immunity in humansInfluence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cellsProstaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes.Prostaglandins, thromboxanes and leukotrienes in clinical medicineEnhancement of lymphocyte blastogenic and delayed hypersensitivity skin responses by indomethacinIsolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics.Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell populationIn vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's diseaseAnalysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetateDefeating cancer with antidepressants.Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.Immunological assays as measurements of nutritional status: a review.A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.Mechanism of inhibition of tumour growth by aspirin and indomethacinLymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.Prostaglandin biosynthesis in pulmonary macrophagesEffects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesisEffects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cellsProstaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes.Monocytes regulate osteoclast-activating factor production by releasing prostaglandinsImmune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophagesGamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages.Synovial fluid and blood monocytes/macrophages in rheumatoid arthritis. Influence on polyclonal activation of autologous B lymphocytes.Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibilityStudies of T- and B-cell interactions in adult patients with combined immunodeficiencyAutologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.Suppressor cell regulation of cell-mediated immune responses in renal infection in vitro modulation of suppressor cell activity.Spectrum of immunodeficiencies with Hodgkin's diseaseStage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
P2860
Q24669705-D57BFFAD-C9E3-4D95-9160-8DE3456F9A67Q24681187-8259BA61-C808-44FA-9997-2085B3126869Q33822380-B584C876-766F-48BB-A7AF-A7E7198CA055Q33832289-74FE3E33-F277-4CBE-ACEB-3B1D5D77D232Q33908843-76ADC8F5-CF1C-40D3-8013-647A3E9371FCQ33990526-352C0C9B-095A-40CF-941A-57FA1282538CQ34076313-439A8CE1-06D0-4249-8FA0-23959551E62CQ34081907-DF763BB6-D0D6-4E1E-9C21-B38C36EC74D5Q34096224-86FF675E-9FF1-4BED-99F5-09ACFFFE6392Q34192889-7081C230-DFDC-4766-B2BA-E3E728807F5BQ34446959-B565EBBD-668F-4E87-BB2F-287390433BDAQ34476526-263F5B2C-FE12-4740-8CD7-9EDE0EB982A9Q34494506-A0C11487-AEE2-4EBB-A721-D41C1FFDC7E9Q34496019-09190F9C-3C23-44AB-BF82-6886DC246055Q34519530-736506EC-C343-4032-A127-1EA900843A7EQ34607846-A7E1D09B-49D6-471B-9CD0-917A0F53658AQ34616508-C53B202C-9991-4F53-A095-184394F6CF29Q35207019-80EB1094-AE69-4EC4-AB76-BFA59B48015BQ35576747-31C84B55-13D2-4C3A-A458-716F3B266831Q35602233-5BD1A862-B767-40FD-90BE-6CA30D6D9E60Q35841174-27D5F0E4-E09D-4585-B4E1-BC3647F0AA1BQ35876186-B771536D-E1F7-4D4F-AD52-0DBAA882EB37Q35948345-A316BA93-72FD-457B-9FEC-C42AA767E854Q36042640-4744CE32-E036-48C3-BB40-F931D17DB382Q36046235-189FC0BF-89D4-4502-95E0-27CA28554EFDQ36093114-FB4C83A8-F53D-4E30-BE0A-E2DE353CDBC6Q36095877-E1EC7098-9157-4742-91EC-2330C958BC7EQ36337083-A6A8B586-0258-4BD1-BA39-C2E63F30F62AQ36341112-97C10F6D-DF26-46EE-8F66-59BDA76E0E89Q36342717-CCB0D03C-A0E8-46D0-AFAF-CABC394394B9Q36348467-29790B70-06C2-4931-B498-C547591EACB9Q36435104-88645635-99E8-4DDC-9FF0-C718E1AF44DEQ36599284-2A182BC7-76A5-472A-8916-3FDEB3555556Q36639902-CF08A5CD-13BB-4DF2-A78D-B75A5EAE4D76Q37020415-450030CB-082B-45A3-9F89-55C9B3818444Q37024091-426FA2BE-0DE7-4B41-8098-5C4C15643761Q37027120-D8D6C5DC-FA94-404C-B036-CE6FDBE90A88Q37027154-5A7F123C-68BA-4857-A379-EE80841978E9Q37028130-F2AC36EA-73BF-4428-B09B-C92E3BEB17AEQ37032114-8915EB5A-EF3B-49F8-8D27-302F46C59AE7
P2860
Prostaglandin-producing suppressor cells in Hodgkin's disease.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Prostaglandin-producing suppressor cells in Hodgkin's disease.
@en
type
label
Prostaglandin-producing suppressor cells in Hodgkin's disease.
@en
prefLabel
Prostaglandin-producing suppressor cells in Hodgkin's disease.
@en
P2093
P1476
Prostaglandin-producing suppressor cells in Hodgkin's disease.
@en
P2093
Bankhurst AD
Goodwin JS
Messner RP
Williams RC Jr
P304
P356
10.1056/NEJM197711032971802
P407
P577
1977-11-01T00:00:00Z